About Semba Biosciences
Semba Biosciences is a Healthcare company based in Madison (United States) founded in 2005, and was acquired by Tosoh Bioscience in October 2021. Provider of systems for molecular separation based on simulated moving bed chromatography (SMBC). Semba Biosciences has raised $5.85 million across 10 funding rounds from investors including Wisconsin Department of Commerce, Tosoh Bioscience and WEDC. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Chromatography. Its legal entity is SEMBA BIOSCIENCES INC. Its competitors include ChromaTan, Sepax Technologies and Sepragen; 3 of its 3 listed competitors have raised funding.
Company details
Semba Biosciences was founded in 2005 in Madison, United States, and operates in the biotechnology sector. Continuous chromatography platforms for process development and single-use manufacturing are offered, along with columns for small molecule and biomolecular separation, and related reagents. These products are applied in the separation of monoclonal antibodies, recombinant proteins, natural products such as nutraceuticals and food ingredients, sugars, amino acids, organic acids, fatty acids, and enantiomers.
- Headquarters Madison, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website sembabio.com
- Social LinkedIn X
- Acquired by Tosoh Bioscience (Oct 2021)
- Legal Name Semba Biosciences Inc
- Total Equity Funding$5.85M (USD)
in 10 rounds
- Latest Funding Round$3M (USD), Series A
Nov 2018
- InvestorsWisconsin Department of Commerce
& 5 more
- Acquired byTosoh Bioscience
(Oct 2021)
Funding Insights of Semba Biosciences
Semba Biosciences has successfully raised a total of $5.85M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.85M
- Total Rounds 10
- Last Round Series A — $3M
- First Round $500,000
(Nov 2007)
- Investors Count 6
All 10 funding rounds of Semba Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2018 | $3M | Series A | – | Tosoh Bioscience | – |
| Jan 2015 | $75,000 | Grant | – | – | |
| Jan 2015 | $511,175 | Seed | – | – | – |
| Sep 2012 | $225,000 | Grant | – | – | – |
| Dec 2010 | $875,000 | Seed | – | – | – |
| May 2010 | $120,000 | Debt – Conventional | – | – | – |
| Jun 2009 | $250,000 | Debt – Conventional | – | – | |
| Jun 2009 | $400,000 | Debt – Conventional | – | – | |
| Mar 2009 | $960,000 | Seed | – | – | – |
| Nov 2007 | $500,000 | Seed | – | – |
6 investors in total: 6 institutional.
Investors in Semba Biosciences
Semba Biosciences has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Wisconsin Department of Commerce, Tosoh Bioscience and WEDC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed venture capital funding is provided by Kegonsa Seed Fund. | kegonsaseedfund.com | United States | ||
Offers biomolecular separation instruments and clinical analyzers for healthcare applications. | 1935 | tosohbioscience.com | Tokyo, Japan | |
Economic development support is provided for businesses and communities in Wisconsin. | inwisconsin.com | Madison, United States | ||
Offers free business consulting and resources for technology innovation funding. | 2002 | wisconsinsbir.org | Madison, United States | |
Government entity focused on electronic safety and licensing application | commerce.wi.gov | United States | ||
Offers affordable workforce housing and gap financing for small businesses. | 1977 | mdcorp.org | Madison, United States |
Investor details for Semba Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Semba Biosciences
1 people are tracked at Semba Biosciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Robert Mierendorf | President and Chief Executive Officer | Leadership |
Complete people profiles for Semba Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Semba Biosciences
4 dated milestones of Semba Biosciences across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Semba Biosciences is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Series A, of $3.0M.
- Exit Acquired by Tosoh Bioscience.
Competitors of Semba Biosciences
Semba Biosciences has 3 listed competitors in our database, 3 of them funded. They include ChromaTan, Sepax Technologies and Sepragen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| chromatan.com | 2009 | State College, United States | $5.32M | Continuous countercurrent tangential chromatography separation technology is developed. | ||
| sepax-tech.com | 2002 | Newark, United States | $109.24M | 57 | Solutions for chromatographic biomolecular separation are developed and provided. | |
| sepragen.com | 1987 | Hayward, United States | $5M | 19 | Biomolecular separation technologies are enabled for bioprocessing applications. |
Detailed competitors of Semba Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Semba Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Semba Biosciences
Complete news archive for Semba Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Semba Biosciences
Semba Biosciences was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Semba Biosciences is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Semba Biosciences is a funded company, having raised a total of $5.85M across 10 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Nov 2007.
Semba Biosciences was founded in 2005 in Madison, United States, and operates in the biotechnology sector. Continuous chromatography platforms for process development and single-use manufacturing are offered, along with columns for small molecule and biomolecular separation, and related reagents. These products are applied in the separation of monoclonal antibodies, recombinant proteins, natural products such as nutraceuticals and food ingredients, sugars, amino acids, organic acids, fatty acids, and enantiomers.
Semba Biosciences's top competitors include ChromaTan, Sepragen and Sepax Technologies.
Semba Biosciences has 6 investors. Key investors include Wisconsin Department of Commerce, Tosoh Bioscience, WEDC, Wisconsin SBIR, and Madison Development.
Semba Biosciences operates through Semba Biosciences Inc.
Yes. Semba Biosciences was acquired by Tosoh Bioscience in October 2021.